Albert D. Mason Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$699K Sell
5,012
-120
-2% -$16.8K 0.45% 77
2025
Q4
$630K Sell
5,132
-19
-0.4% -$2.31K 0.41% 84
2025
Q3
$572K Sell
5,151
-110
-2% -$12.5K 0.37% 93
2025
Q2
$583K Sell
5,261
-203
-4% -$21.6K 0.42% 84
2025
Q1
$612K Sell
5,464
-410
-7% -$42.3K 0.42% 88
2024
Q4
$543K Sell
5,874
-20
-0.3% -$1.8K 0.36% 93
2024
Q3
$494K Sell
5,894
-130
-2% -$9.92K 0.32% 99
2024
Q2
$413K Sell
6,024
-100
-2% -$6.67K 0.28% 108
2024
Q1
$449K Sell
6,124
-44
-0.7% -$3.38K 0.28% 113
2023
Q4
$500K Buy
6,168
+49
+0.8% +$3.81K 0.33% 107
2023
Q3
$459K Buy
6,119
+204
+3% +$15.7K 0.33% 110
2023
Q2
$456K Sell
5,915
-358
-6% -$28.6K 0.31% 112
2023
Q1
$520K Sell
6,273
-111
-2% -$9.19K 0.36% 107
2022
Q4
$548K Buy
6,384
+48
+0.8% +$3.8K 0.39% 103
2022
Q3
$391K Buy
6,336
+278
+5% +$17.5K 0.31% 116
2022
Q2
$374K Buy
6,058
+50
+0.8% +$3.1K 0.28% 122
2022
Q1
$357K Buy
6,008
+230
+4% +$14.7K 0.23% 128
2021
Q4
$420K Buy
+5,778
New +$398K 0.25% 128
2018
Q3
Sell
-3,118
Closed -$221K 137
2018
Q2
$221K Sell
3,118
-2,510
-45% -$177K 0.16% 127
2018
Q1
$424K Buy
+5,628
New +$447K 0.32% 108

Other funds holding GILD

Albert D. Mason Inc's GILD Position: Q1 2026 in Review

Albert D. Mason Inc reduced its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, selling an estimated $16.8K and leaving 5,012 shares worth $699K. The position accounts for 0.45% of the portfolio, ranked #77.

Albert D. Mason Inc first reported a position in GILD in Q1 2018 and has held it in 20 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Albert D. Mason Inc held 5,012 shares of Gilead Sciences worth $699K as of Q1 2026.
  • Albert D. Mason Inc sold 120 Gilead Sciences shares in Q1 2026, an estimated $16.8K.
  • Gilead Sciences made up 0.45% of Albert D. Mason Inc's portfolio in Q1 2026, its #77 holding.
  • Albert D. Mason Inc first reported a position in Gilead Sciences in Q1 2018 and has held it in 20 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Albert D. Mason Inc's 13F filing for Q1 2026, filed 15 Apr 2026.